Skip to content

Cartesian Therapeutics, Inc.

RNAC

CIK 0001453687 · Pharmaceutical Preparations · Nasdaq

  • SELECTA BIOSCIENCES INC (until 2023-11-13)
← back to feed
Revenue (TTM)
$400K
−99.0% YoY Q1 Apr 2026
Net Income (TTM)
−$76.91M
−68.3% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$3.02
−11.8% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-22,816.3%
Q1 Apr 2026
Net Margin
-19,227.0%
Q1 Apr 2026
Free Cash Flow (TTM)
−$71.76M
Q1 Apr 2026
Cash
$118.64M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
29.38M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings